[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechCH Biotech Hangout Biotech Hangout posts on X about $xbi, $ions, sentiment, white house the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1353752829266194434/interactions)  - X Week XXXXX -XXXX% - X Month XXXXXX +1.40% - X Months XXXXXXX -XX% - X Year XXXXXXX -XXXX% ### Mentions: X [#](/creator/twitter::1353752829266194434/posts_active)  - X Week XX +33% - X Month XX -XXXX% - X Months XXX -XX% - X Year XXX -XXXX% ### Followers: XXXXXX [#](/creator/twitter::1353752829266194434/followers)  - X Week XXXXXX +0.25% - X Month XXXXXX +1.40% - X Months XXXXXX +8.80% - X Year XXXXXX +18% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1353752829266194434/influencer_rank)  ### Social Influence [#](/creator/twitter::1353752829266194434/influence) --- **Social category influence** [finance](/list/finance) XXXX% [technology brands](/list/technology-brands) XXXX% **Social topic influence** [$xbi](/topic/$xbi) #46, [$ions](/topic/$ions) 8.33%, [sentiment](/topic/sentiment) 4.17%, [white house](/topic/white-house) 4.17%, [$bcrx](/topic/$bcrx) 4.17%, [$atxs](/topic/$atxs) 4.17%, [$700m](/topic/$700m) 4.17%, [$legn](/topic/$legn) 4.17%, [market sentiment](/topic/market-sentiment) 4.17%, [fda](/topic/fda) XXXX% **Top accounts mentioned or mentioned by** [@ericschmidt151](/creator/undefined) [@samfazeli8](/creator/undefined) [@jmaraganore](/creator/undefined) [@soowannaway](/creator/undefined) [@matteispaul](/creator/undefined) [@bradloncar](/creator/undefined) [@cngarabedian](/creator/undefined) [@tlorriman](/creator/undefined) [@yaronwerber](/creator/undefined) [@artsstocks](/creator/undefined) [@statnews](/creator/undefined) [@daphnezohar](/creator/undefined) [@timopler](/creator/undefined) [@biotech1](/creator/undefined) [@jacobplieth](/creator/undefined) [@lubagreenwood](/creator/undefined) [@mpreminger](/creator/undefined) [@brianskorney](/creator/undefined) [@yaireinhorn](/creator/undefined) [@debpalestrant](/creator/undefined) **Top assets mentioned** [Bitcoin Incognito (XBI)](/topic/$xbi) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) ### Top Social Posts [#](/creator/twitter::1353752829266194434/posts) --- Top posts by engagements in the last XX hours "On todays #BiotechHangout @MatteisPaul @JMaraganore @EricSchmidt151 & @soowannaway (Graig Suvannaveijh) will discuss market sentiment strong $XBI & whether were ready for biotech IPOs plus the latest on policy: FDA Commissioners National Priority Voucher (CNPV) recipients White House GLP-1 pricing comments plus HAE consolidation: $BCRX/$ATXS $700M deal regulatory: $LEGN label update & Q3 Carvykti sales FDAs OAI letter to $NVO mfg facility & impact on $SKKR & $REGN $BCAX BTD for head & neck cancer @statnews Summit takeaways company news: $REGN/Decibel hearing loss data $XNCR leaked abstracts" [X Link](https://x.com/BiotechCH/status/1979181209079939554) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T13:42Z 15.1K followers, 6362 engagements "On todays #BiotechHangout @MatteisPaul @SamFazeli8 @JMaraganore @soowannaway (Graig Suvannaveijh) discuss the $XBI & sector performance drivers $SNYs X% stock dip despite Ph3 eczema success $INSMs incredible year & readthrough from $UTHRs Ph3 IPF data Corsera Health $50M launch #ESC2025: $IONS & $ARWR ApoC3 data ASO vs RNAi discussion tracking upcoming data: big year for AD readouts plus QUREs AMT-130 $HRMYs ZYN00 #WCLC25: $SMMTs ivonescimab & $AZNs FLAURA2 $AXSM AXS-05/Auvelity expected sNDA submission plus discussion themes: obesity readouts - is obesity a zero sum game biomarkers - do" [X Link](https://x.com/BiotechCH/status/1963950153967993086) [@BiotechCH](/creator/x/BiotechCH) 2025-09-05T12:59Z 15.1K followers, 5282 engagements "President Trump says Ozempic (GLP-1) prices will drop from $1300 to $XXX but this was walked back by Dr. Oz who clarified the number wasnt official and prices may land higher. My guess is if these pharma companies with all their sophistication and financial planning and analysis powers are cutting a deal with the government it's probably going to be an okay deal economically for them. Of course a lot has been made of the fact that Pfizer hasnt had to restate guidance or refile any SEC paperwork any changes to its financial condition in the wake of its deal with the White House.I think we can" [X Link](https://x.com/BiotechCH/status/1979227064566788275) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T16:44Z 15.1K followers, XXX engagements "$IONS Innovation Day occurred earlier this week. @YaronWerber attended and shares that there are X new things: One guiding to profitability in 2028 peak sales of over X billion X billion from their pipeline X billion from collaborators. Two was that everything they're doing is cool and all but there's always somebody behind them who's better with siRNA. Well they have their own siRNA platform now and they've unveiled out of nowhere phase one data for the apoC-III showing XX% reduction And then finally they have an siRNA platform now even targeting muscle and they're going into heart failure" [X Link](https://x.com/BiotechCH/status/1976703735314120931) [@BiotechCH](/creator/x/BiotechCH) 2025-10-10T17:37Z 15.1K followers, XXX engagements "The neurodegenerative disease space is so tough. Weve been waiting for the results of this $ALEC data for a long time shares @soowannaway (Graig Suvannavejh) on $ALECs topline Ph3 data in frontotemporal dementia expected by mid-November. We're awaiting the results of the study where there are two co-primary endpoints a change to the SAP for the study but there is an efficacy readout and the addition of a biomarker-based endpoint. Clearly the market is not ascribing a lot of value or expectation that this is going to work and given the complexities of the disease and that we have prior data" [X Link](https://x.com/BiotechCH/status/1979237222768320648) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T17:25Z 15.1K followers, 1467 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechCH Biotech Hangout
Biotech Hangout posts on X about $xbi, $ions, sentiment, white house the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XXXX%
- X Month XXXXXX +1.40%
- X Months XXXXXXX -XX%
- X Year XXXXXXX -XXXX%
Mentions: X #
- X Week XX +33%
- X Month XX -XXXX%
- X Months XXX -XX%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.25%
- X Month XXXXXX +1.40%
- X Months XXXXXX +8.80%
- X Year XXXXXX +18%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XXXX% technology brands XXXX%
Social topic influence $xbi #46, $ions 8.33%, sentiment 4.17%, white house 4.17%, $bcrx 4.17%, $atxs 4.17%, $700m 4.17%, $legn 4.17%, market sentiment 4.17%, fda XXXX%
Top accounts mentioned or mentioned by @ericschmidt151 @samfazeli8 @jmaraganore @soowannaway @matteispaul @bradloncar @cngarabedian @tlorriman @yaronwerber @artsstocks @statnews @daphnezohar @timopler @biotech1 @jacobplieth @lubagreenwood @mpreminger @brianskorney @yaireinhorn @debpalestrant
Top assets mentioned Bitcoin Incognito (XBI) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Arrowhead Research Corporation (ARWR)
Top Social Posts #
Top posts by engagements in the last XX hours
"On todays #BiotechHangout @MatteisPaul @JMaraganore @EricSchmidt151 & @soowannaway (Graig Suvannaveijh) will discuss market sentiment strong $XBI & whether were ready for biotech IPOs plus the latest on policy: FDA Commissioners National Priority Voucher (CNPV) recipients White House GLP-1 pricing comments plus HAE consolidation: $BCRX/$ATXS $700M deal regulatory: $LEGN label update & Q3 Carvykti sales FDAs OAI letter to $NVO mfg facility & impact on $SKKR & $REGN $BCAX BTD for head & neck cancer @statnews Summit takeaways company news: $REGN/Decibel hearing loss data $XNCR leaked abstracts"
X Link @BiotechCH 2025-10-17T13:42Z 15.1K followers, 6362 engagements
"On todays #BiotechHangout @MatteisPaul @SamFazeli8 @JMaraganore @soowannaway (Graig Suvannaveijh) discuss the $XBI & sector performance drivers $SNYs X% stock dip despite Ph3 eczema success $INSMs incredible year & readthrough from $UTHRs Ph3 IPF data Corsera Health $50M launch #ESC2025: $IONS & $ARWR ApoC3 data ASO vs RNAi discussion tracking upcoming data: big year for AD readouts plus QUREs AMT-130 $HRMYs ZYN00 #WCLC25: $SMMTs ivonescimab & $AZNs FLAURA2 $AXSM AXS-05/Auvelity expected sNDA submission plus discussion themes: obesity readouts - is obesity a zero sum game biomarkers - do"
X Link @BiotechCH 2025-09-05T12:59Z 15.1K followers, 5282 engagements
"President Trump says Ozempic (GLP-1) prices will drop from $1300 to $XXX but this was walked back by Dr. Oz who clarified the number wasnt official and prices may land higher. My guess is if these pharma companies with all their sophistication and financial planning and analysis powers are cutting a deal with the government it's probably going to be an okay deal economically for them. Of course a lot has been made of the fact that Pfizer hasnt had to restate guidance or refile any SEC paperwork any changes to its financial condition in the wake of its deal with the White House.I think we can"
X Link @BiotechCH 2025-10-17T16:44Z 15.1K followers, XXX engagements
"$IONS Innovation Day occurred earlier this week. @YaronWerber attended and shares that there are X new things: One guiding to profitability in 2028 peak sales of over X billion X billion from their pipeline X billion from collaborators. Two was that everything they're doing is cool and all but there's always somebody behind them who's better with siRNA. Well they have their own siRNA platform now and they've unveiled out of nowhere phase one data for the apoC-III showing XX% reduction And then finally they have an siRNA platform now even targeting muscle and they're going into heart failure"
X Link @BiotechCH 2025-10-10T17:37Z 15.1K followers, XXX engagements
"The neurodegenerative disease space is so tough. Weve been waiting for the results of this $ALEC data for a long time shares @soowannaway (Graig Suvannavejh) on $ALECs topline Ph3 data in frontotemporal dementia expected by mid-November. We're awaiting the results of the study where there are two co-primary endpoints a change to the SAP for the study but there is an efficacy readout and the addition of a biomarker-based endpoint. Clearly the market is not ascribing a lot of value or expectation that this is going to work and given the complexities of the disease and that we have prior data"
X Link @BiotechCH 2025-10-17T17:25Z 15.1K followers, 1467 engagements